Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice

BACKGROUND: The usefulness of the Oncomine Dx Target test (Oncomine Dx), a next‐generation sequencing (NGS) test, has already been proven in clinical trials. However, NGS requires high‐quality tumor samples and takes a long time to generate results. The feasibility of NGS for use in advanced non‐sma...

Descripción completa

Detalles Bibliográficos
Autores principales: Ariyasu, Ryo, Uchibori, Ken, Ninomiya, Hironori, Ogusu, Shinsuke, Tsugitomi, Ryosuke, Manabe, Ryo, Sakamaoto, Hiroaki, Tozuka, Takehiro, Yoshida, Hiroshi, Amino, Yoshiaki, Kitazono, Satoru, Yanagitani, Noriko, Takeuchi, Kengo, Nishio, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882378/
https://www.ncbi.nlm.nih.gov/pubmed/33350072
http://dx.doi.org/10.1111/1759-7714.13786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7882378/
https://www.ncbi.nlm.nih.gov/pubmed/33350072
http://dx.doi.org/10.1111/1759-7714.13786

Ejemplares similares